Literature DB >> 12029075

Localization of heparanase in normal and pathological human placenta.

Ronit Haimov-Kochman1, Yael Friedmann, Diana Prus, Debra S Goldman-Wohl, Caryn Greenfield, Eyal Y Anteby, Ayelet Aviv, Israel Vlodavsky, Simcha Yagel.   

Abstract

Degradation of extracellular matrix (ECM) components is critical for invasion. Heparan sulphate proteoglycans are abundant in the ECM of the placenta and the decidua, hence their degradation may disassemble the matrix and facilitate placentation and trophoblast invasion. This study investigates the expression of heparanase in normal and pathological placentation using RT-PCR, in-situ hybridization and immunohistochemistry analysis to detect heparanase in specific cells of the placenta and at the fetal-maternal interface throughout pregnancy. Heparanase was observed in villous cytotrophoblasts (CT), syncytial trophoblasts (ST) and in intermediate trophoblast cell columns in normal first trimester, molar and ectopic pregnancies. The heparanase protein was preferentially expressed in the endothelium of fetal capillaries, and to a much lesser extent in larger fetal vessels. Extravillous trophoblasts (EVT) invading the decidua and the maternal vessels were also heparanase positive. In the second and third trimesters, villous CT remained heparanase positive whereas ST showed variable heparanase expression. EVT invading the placental implantation site were also positively stained. A similar pattern was observed in samples obtained from pre-eclamptic placentae and from placenta accreta. Our results indicate consistent expression of heparanase in normal and abnormal placenta, in small fetal vessels and in a variety of trophoblast subpopulations with different invasive potentials.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12029075     DOI: 10.1093/molehr/8.6.566

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  7 in total

1.  [Long non-coding RNAs show different expression profiles and display competing endogenous RNA potential in placenta accreta spectrum disorders].

Authors:  Shuzhen Wu; Huishan Zhang; Yan Liu; Rui Wang; Shaoxin Ye; Meng Zeng; Zhengping Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

2.  Heparanase expression in periapical granulomas and radicular cysts.

Authors:  S Elad; Y Sherman; A Palmon; I Vlodavsky; R Or
Journal:  Odontology       Date:  2011-10-22       Impact factor: 2.634

3.  Overexpression of heparanase is associated with preeclampsia by inhibiting invasion of trophocytes.

Authors:  Yan-Yun Wang; Rong Zhou; Bin Zhou; Tao Wang; Lin Zhang; Dong Luo
Journal:  Int J Clin Exp Med       Date:  2015-10-15

4.  Cell surface expression and secretion of heparanase markedly promote tumor angiogenesis and metastasis.

Authors:  Orit Goldshmidt; Eyal Zcharia; Rinat Abramovitch; Shula Metzger; Helena Aingorn; Yael Friedmann; Volker Schirrmacher; Eduardo Mitrani; Israel Vlodavsky
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-03       Impact factor: 11.205

Review 5.  A Review on the Pathogenesis and Clinical Management of Placental Site Trophoblastic Tumors.

Authors:  Xuan Feng; Zhi Wei; Sai Zhang; Yan Du; Hongbo Zhao
Journal:  Front Oncol       Date:  2019-11-28       Impact factor: 6.244

6.  Clinical significance of heparanase splice variant (t5) in renal cell carcinoma: evaluation by a novel t5-specific monoclonal antibody.

Authors:  Uri Barash; Gil Arvatz; Roy Farfara; Inna Naroditsky; Ilana Doweck; Sari Feld; Ofer Ben-Izhak; Neta Ilan; Ofer Nativ; Israel Vlodavsky
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

Review 7.  Mammalian heparanase: what is the message?

Authors:  Veronique Vreys; Guido David
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.